Medicine

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.

P. Trzonkowski, M. Bieniaszewska, Jolanta Juścińska, A. Dobyszuk, A. Krzystyniak, Natalia Marek, J. Myśliwska, A. Hellmann

2009.10.1CLINICAL IMMUNOLOGY

DOI: 10.1016/j.clim.2009.06.001

tlooto Summary

The therapy allowed for significant alleviation of the symptoms and reduction of pharmacologic immunosuppression in the case of chronic GvHD, while in the cases of grade IV acute Gv HD it only transiently improved the condition, for the longest time within all Immunosuppressants used nonetheless.

Abstract

Abstract is not available.

Citation format

TRZONKOWSKI, P., et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- t regulatory cells. CLINICAL IMMUNOLOGY, 2009, 133 1: 22–6.